Niklason E. Laura's Insider Trades & SAST Disclosures
Niklason E. Laura's most recent trade in Humacyte Inc was a trade of 1,130,311 Stock Options (right to buy) done . Disclosure was reported to the exchange on Jan. 21, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Niklason E. Laura.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Humacyte Inc | Laura E. Niklason | Director, President, CEO and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 1,130,311 | 1,130,311 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Niklason E. Laura | Director, President, CEO and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2024 | 525 | 2,625 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Laura E. Niklason | Director, President, CEO and Director | Purchase of securities on an exchange or from another person at price $ 4.44 per share. | 19 Nov 2024 | 1,797 | 243,851 | - | 4.4 | 7,979 | Common Stock |
| Humacyte Inc | Laura E. Niklason | Director, President, CEO and Director | Sale of securities on an exchange or to another person at price $ 4.44 per share. | 18 Nov 2024 | 811,172 | 2,419,712 | - | 4.4 | 3,601,604 | Common Stock |
| Humacyte Inc | Laura E. Niklason | Director, President, CEO and Director | Sale of securities on an exchange or to another person at price $ 4.34 per share. | 18 Nov 2024 | 427,459 | 1,992,253 | - | 4.3 | 1,855,172 | Common Stock |
| Humacyte Inc | Laura E. Niklason | Director, President, CEO and Director | Sale of securities on an exchange or to another person at price $ 4.40 per share. | 18 Nov 2024 | 261,369 | 1,730,884 | - | 4.4 | 1,150,024 | Common Stock |
| Humacyte Inc | Laura E. Niklason | Director, President, CEO and Director | Sale of securities on an exchange or to another person at price $ 5.23 per share. | 09 Sep 2024 | 288,674 | 3,230,884 | - | 5.2 | 1,509,765 | Common Stock |
| Humacyte Inc | Laura E. Niklason | Director, President, CEO and Director | Sale of securities on an exchange or to another person at price $ 5.42 per share. | 09 Sep 2024 | 157,704 | 3,519,558 | - | 5.4 | 854,756 | Common Stock |
| Humacyte Inc | Laura E. Niklason | Director, President, CEO and Director | Purchase of securities on an exchange or from another person at price $ 6.55 per share. | 29 Aug 2024 | 1,222 | 242,054 | - | 6.5 | 7,998 | Common Stock |
| Humacyte Inc | Laura E. Niklason | Director, President, CEO and Director | Sale of securities on an exchange or to another person at price $ 6.35 per share. | 27 Aug 2024 | 352,112 | 3,677,262 | - | 6.3 | 2,235,911 | Common Stock |
| Humacyte Inc | Laura E. Niklason | Director, President, CEO and Director | Sale of securities on an exchange or to another person at price $ 6.47 per share. | 27 Aug 2024 | 277,090 | 4,029,374 | - | 6.5 | 1,792,772 | Common Stock |
| Humacyte Inc | Laura E. Niklason | Director, President, CEO and Director | Sale of securities on an exchange or to another person at price $ 6.71 per share. | 27 Aug 2024 | 252,676 | 4,306,464 | - | 6.7 | 1,695,456 | Common Stock |
| Humacyte Inc | Laura E. Niklason | Director, President, CEO and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 50,000 | 50,000 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Laura E. Niklason | Director, President, CEO and Director | Sale of securities on an exchange or to another person at price $ 7.09 per share. | 11 Jun 2024 | 282,000 | 4,907,288 | - | 7.1 | 2,000,000 | Common Stock |
| Humacyte Inc | Laura E. Niklason | Director, President, CEO and Director | Sale of securities on an exchange or to another person at price $ 7.30 per share. | 11 Jun 2024 | 271,518 | 4,559,140 | - | 7.3 | 1,982,081 | Common Stock |
| Humacyte Inc | Laura E. Niklason | Director, President, CEO and Director | Sale of securities on an exchange or to another person at price $ 7.02 per share. | 11 Jun 2024 | 76,630 | 4,830,658 | - | 7.0 | 537,943 | Common Stock |
| Humacyte Inc | Laura E. Niklason | Director, President, CEO and Director | Purchase of securities on an exchange or from another person at price $ 6.35 per share. | 04 Jun 2024 | 2,362 | 240,832 | - | 6.4 | 14,999 | Common Stock |
| Humacyte Inc | Laura E. Niklason | Director, President, CEO and Director | Purchase of securities on an exchange or from another person at price $ 7.37 per share. | 03 Jun 2024 | 2,050 | 238,470 | - | 7.4 | 15,109 | Common Stock |
| Humacyte Inc | Laura E. Niklason | Director, President, CEO and Director | Sale of securities on an exchange or to another person at price $ 7.78 per share. | 31 May 2024 | 716,573 | 5,474,567 | - | 7.8 | 5,574,938 | Common Stock |
| Humacyte Inc | Laura E. Niklason | Director, President, CEO and Director | Sale of securities on an exchange or to another person at price $ 7.42 per share. | 31 May 2024 | 190,214 | 5,191,140 | - | 7.4 | 1,411,388 | Common Stock |
| Humacyte Inc | Laura E. Niklason | Director, President, CEO and Director | Sale of securities on an exchange or to another person at price $ 8.93 per share. | 31 May 2024 | 93,213 | 5,381,354 | - | 8.9 | 832,392 | Common Stock |
| Humacyte Inc | Laura E. Niklason | Director, President, CEO and Director | Sale of securities on an exchange or to another person at price $ 7.28 per share. | 31 May 2024 | 1,852 | 5,189,288 | - | 7.3 | 13,483 | Common Stock |
| Humacyte Inc | E. Niklason Laura | Director, President, CEO and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2023 | 803,000 | 803,000 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Niklason E. Laura | Director, President, CEO and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2023 | 525 | 2,100 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Laura E. Niklason | Director, President, CEO and Director | Sale of securities on an exchange or to another person at price $ 3.57 per share. | 17 Aug 2023 | 626,979 | 8,793,583 | - | 3.6 | 2,238,315 | Common Stock |
| Humacyte Inc | Laura E. Niklason | Director, President, CEO and Director | Sale of securities on an exchange or to another person at price $ 3.39 per share. | 17 Aug 2023 | 602,443 | 8,191,140 | - | 3.4 | 2,042,282 | Common Stock |
| Humacyte Inc | Laura E. Niklason | Director, President, CEO and Director | Sale of securities on an exchange or to another person at price $ 3.68 per share. | 17 Aug 2023 | 570,174 | 9,420,562 | - | 3.7 | 2,098,240 | Common Stock |
| Humacyte Inc | Laura E. Niklason | Director, President, CEO and Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 3.12 per share. | 15 Jun 2023 | 500,000 | 9,990,736 | - | 3.1 | 1,558,750 | Common Stock |
| Humacyte Inc | Laura E. Niklason | Director, President, CEO and Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 8,500 | 8,500 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Laura E. Niklason | Director, President, CEO and Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.60 per share. | 13 Jun 2023 | 4,875,000 | 10,490,736 | - | 2.6 | 12,675,000 | Common Stock |
| Humacyte Inc | Laura E. Niklason | Director, President, CEO and Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.75 per share. | 25 May 2023 | 2,625,000 | 15,365,736 | - | 2.8 | 7,218,750 | Common Stock |
| Humacyte Inc | Laura E. Niklason | Director, President, CEO and Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 100,000 | 162,596 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Laura E. Niklason | Director, President, CEO and Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.19 per share. | 01 Mar 2023 | 100,000 | 1,270,240 | - | 1.2 | 119,000 | Common Stock |
| Humacyte Inc | Laura E. Niklason | Director, President, CEO and Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.53 per share. | 16 Dec 2022 | 239,538 | 17,990,736 | - | 2.5 | 606,031 | Common Stock |
| Humacyte Inc | Laura E. Niklason | Director, President, CEO and Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.54 per share. | 15 Dec 2022 | 10,000 | 1,170,240 | - | 2.5 | 25,400 | Common Stock |
| Humacyte Inc | Laura E. Niklason | Director, President, CEO and Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.84 per share. | 13 Dec 2022 | 330,000 | 18,600,004 | - | 2.8 | 937,200 | Common Stock |
| Humacyte Inc | Laura E. Niklason | Director, President, CEO and Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.76 per share. | 13 Dec 2022 | 276,304 | 18,323,700 | - | 2.8 | 762,599 | Common Stock |
| Humacyte Inc | Laura E. Niklason | Director, President, CEO and Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.63 per share. | 13 Dec 2022 | 93,426 | 18,230,274 | - | 2.6 | 245,710 | Common Stock |
| Humacyte Inc | Laura E. Niklason | Director, President, CEO and Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2022 | 444,500 | 444,500 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Laura E. Niklason | Director, President, CEO and Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 4.00 per share. | 15 Sep 2022 | 1,522,500 | 18,930,004 | - | 4 | 6,090,000 | Common Stock |
| Humacyte Inc | Laura E. Niklason | Director, President, CEO and Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.14 per share. | 15 Sep 2022 | 2,000 | 1,160,240 | - | 4.1 | 8,280 | Common Stock |
| Humacyte Inc | Laura E. Niklason | Director, President, CEO and Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 8,500 | 8,500 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Laura E. Niklason | Director, President, CEO and Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.83 per share. | 23 May 2022 | 10,000 | 1,158,240 | - | 4.8 | 48,300 | Common Stock |
| Humacyte Inc | Laura E. Niklason | Director, President, CEO and Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 8.88 per share. | 14 Dec 2021 | 125,000 | 585,161 | - | 8.9 | 1,110,625 | Common Stock |
| Humacyte Inc | Laura E. Niklason | Director, President, CEO and Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.32 per share. | 14 Dec 2021 | 76,306 | 710,161 | - | 9.3 | 711,553 | Common Stock |
| Humacyte Inc | Laura E. Niklason | Director, President, CEO and Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.00 per share. | 14 Dec 2021 | 75,000 | 510,161 | - | 9 | 675,000 | Common Stock |
| Humacyte Inc | Laura E. Niklason | Director, President, CEO and Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.80 per share. | 14 Dec 2021 | 23,694 | 786,467 | - | 9.8 | 232,154 | Common Stock |
| Humacyte Inc | Laura E. Niklason | Director, President, CEO and Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Oct 2021 | 8,500 | 8,500 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Laura E. Niklason | Director, President, CEO and Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2021 | 18,930,004 | 18,930,004 | - | - | Common Stock | |
| Humacyte Inc | Laura E. Niklason | Director, President, CEO and Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 10.00 per share. | 26 Aug 2021 | 1,522,500 | 20,452,504 | - | 10 | 15,225,000 | Common Stock |
| Humacyte Inc | Laura E. Niklason | Director, President, CEO and Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2021 | 1,312,984 | 1,312,984 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Laura E. Niklason | Director, President, CEO and Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2021 | 1,148,240 | 1,148,240 | - | - | Common Stock | |
| Humacyte Inc | Laura E. Niklason | Director, President, CEO and Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2021 | 262,596 | 262,596 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Laura E. Niklason | Director, President, CEO and Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2021 | 262,596 | 262,596 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Laura E. Niklason | Director, President, CEO and Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2021 | 157,558 | 157,558 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Laura E. Niklason | Director, President, CEO and Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2021 | 131,298 | 131,298 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Laura E. Niklason | Director, President, CEO and Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2021 | 17,068 | 17,068 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Laura E. Niklason | Director, President, CEO and Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2021 | 13,129 | 13,129 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Laura E. Niklason | Director, President, CEO and Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2021 | 13,129 | 13,129 | - | - | Stock Options (right to buy) | |
| Humacyte Inc | Laura E. Niklason | Director, President, CEO and Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2021 | 1,575 | 1,575 | - | - | Stock Options (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges